Beauty Farm Medical and Health Industry Inc. repurchased 43,500 ordinary shares on 12 May 2026, deploying HK$0.85 million under its Hong Kong-listed share buyback programme. The shares were bought on the Stock Exchange of Hong Kong at prices between HK$19.29 and HK$19.74, translating into a volume-weighted average cost of HK$19.64 per share.

Following the transaction, Beauty Farm’s outstanding share count (excluding treasury shares) fell 0.02% to 249.57 million, down from 249.61 million on 11 May 2026. Treasury stock rose to 2.03 million shares, leaving the total issued share capital unchanged at 251.59 million shares.

The repurchase forms part of the mandate granted on 27 June 2025, which authorises the company to buy back up to 23.58 million shares. To date, Beauty Farm has bought back 2.03 million shares—8.60% of the authorised limit and 0.86% of the company’s issued shares when the mandate was approved.

A moratorium on new share issues or sales of treasury shares is in effect through 11 June 2026, in accordance with Hong Kong listing rules. Management confirmed that the buyback complied with all listing and regulatory requirements.